Abstract: The present disclosure discloses a transmission device of a hybrid vehicle. The transmission device includes an input shaft assembly, a power generation motor input shaft assembly, a driving motor input shaft assembly, an output shaft assembly, a clutch, an accelerating planetary gear train, a decelerating planetary gear train, and a parking mechanism. The input shaft assembly is located at a front end of the transmission device. The power generation motor input shaft assembly is located between the accelerating planetary gear train and the driving motor input shaft assembly. The driving motor input shaft assembly is located between the power generation motor input shaft assembly and the decelerating planetary gear train. The output shaft assembly is located at a tail end of the transmission device. The clutch is located between a power generation motor and a driving motor.

Abstract: A microprocessor includes a cryptographic engine and a controller. The cryptographic engine is configured to execute a cryptographic algorithm. The controller is connected to the cryptographic engine. The controller is configured to receive an access request from a first execution environment. The access request accesses the cryptographic engine to execute the cryptographic algorithm. The access request includes at least identification information. The identification information indicates that the access request is from the first execution environment. The first execution environment is an execution environment of a number N execution environments. N is an integer greater than or equal to 1. The controller is further configured to, based on the identification information, instruct the cryptographic engine to execute the cryptographic algorithm that needs to be executed required by the access request.

Abstract: The present invention provides a copper billet horizontal continuous casting apparatus with a vertical shaft furnace for smelting and a corresponding process. The copper billet horizontal continuous casting apparatus with a vertical shaft furnace for smelting includes: a vertical shaft, a refining furnace, a mixing furnace, a holding furnace, and a continuous casting furnace; wherein the refining furnace comprises a furnace body, and a gas flushing device disposed beneath the furnace body, a gas flushing brick is provided at the chamber bottom wall of the furnace body; a gas inlet device is provided on the vertical shaft furnace; the vertical shaft furnace further includes a detecting device and an adjusting device which are connected with the air inlet device.

Abstract: Disclosed is a sliced cell photovoltaic module, comprising one or more cell units connected in series, wherein each cell unit comprises one cell string sequence or a plurality of cell string sequences connected in series or in parallel; each cell string sequence comprises one cell string or a plurality of cell strings connected in parallel by means of a bus bar; and each cell string comprises a plurality of small cell slices connected in series by means of connection materials; the spacing between the plurality of small cell slices is ?2 to 5 mm, wherein each small cell slice is one of 2-8 independent small cell slices obtained by means of laser cutting a solar cell with a size of 156*156 to 300*300, etc.; each small cell slice has a positive electrode and a back electrode; and the positions of each positive electrode and each back electrode are superposed with each other or are respectively at the edges of two ends of the small cell slice.

Abstract: Some embodiments of the present invention provide an electronic expansion valve and assembling method of electronic expansion valve, the electronic expansion valve includes: a housing; a guide sleeve; a screw; a rotor being drivingly connected with the screw; and a valve needle assembly movably disposed in the housing, one end of the screw being connected with the valve needle assembly so as to drive the valve needle assembly to move axially by means of the screw. A guide segment and a press-fit segment which are in communication with each other are disposed between an inner wall of the housing and an outer wall of the guide sleeve, a spacing between the guide sleeve and the housing located on the guide segment is greater than a spacing between the guide sleeve and the housing located on the press-fit segment.

Abstract: The invention relates to a data transmission method, in particular to a data transmission event used for interconnected dies, comprising read events, write events and interrupt events; the read event comprises read request events and read response events; the write event comprises write data events and write response events; the write data event and the read request event are both sent by the master device and received by the slave device; the writing response event and the read response event are both sent by the slave device and received by the master device.

Abstract: The invention discloses an interface system for an interconnected die and an MPU and a communication method thereof. The system comprises a data interface, an interrupt interface, and a debugging interface; the data interface comprises an SPI interface, a DDR data interface, and a DMA control interface; the interrupt interface is used for receiving an interrupt data packet from the network and parsing the interrupt data packet to obtain a pulse interrupt input required by the MPU; the debugging interface comprises a JTAG-Core debugging interface, which is used for receiving a debugging data packet from the network and translating the debugging data packet into a JTAG protocol for MPU debugging. The invention realizes the expansion of the master device MPU in the high-performance information processing microsystem and the high-speed communication between the master device and the interconnected dies.

Abstract: The invention discloses clock management of chips, in particular to the clock domain system of interconnected dies and its management methods. The clock domain systems of the interconnected dies, comprising: global clock domains used to manage interior networks on die of the interconnected dies, standard protocol interface clock domains used to manage standard protocol conversion modules and interface source synchronous clock domains used to manage expansion synchronization controllers across dies. The clock domain systems of the interconnected dies provided by the invention modularize complicated clock networks by isolating each module from the perspective of clocks and simultaneously initiate clock synchronization among all clock domains, which is easy for interconnected network setups.

Abstract: An infrared zero value diagnosis method and system for a porcelain insulator string are provided.

Abstract: This application discloses a wireless charging system, and pertains to the field of wireless charging technologies. The system includes: a transmit apparatus and a receive apparatus; the transmit apparatus includes an inverter circuit and two transmit electrodes, an input terminal of the inverter circuit is connected to a direct-current power supply, and two output terminals of the inverter circuit are connected to the two transmit electrodes respectively; the receive apparatus includes two receive electrodes and a rectifier circuit, two input terminals of the rectifier circuit are connected to the two receive electrodes respectively, and an output terminal of the rectifier circuit is connected to a load.

Abstract: An infrared zero value diagnosis method and system for a porcelain insulator string are provided.

Abstract: The present invention discloses a nicotinyl alcohol ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to nicotinyl alcohol ether derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases.

Abstract: The present invention discloses a benzyl phenyl ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to benzyl phenyl ether derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases.

Abstract: The present invention discloses a nicotinyl alcohol ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to nicotinyl alcohol ether derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases.

Abstract: The present invention discloses a phenylate derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to phenylate derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases.

Abstract: Provided is a method for preparing 2-hydroxy-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative represented by formula (I). The method comprises the following steps: (1) preparing 3-aryl-2-substituted toluene derivative 2 by using 3-iodo-2-substituted toluene derivative 1 and aryl boronic acid 5 or aryl boronate as starting materials; (2) preparing a benzyl halide derivative 3 by using 3-aryl-2-substituted toluene derivative 2 as starting materials; and (3) preparing 4-(2, 3-disubstituted benzyloxy)-2-hydroxy-5-substituted benzaldehyde derivative (I) by using benzyl halide derivative 3 and 2,4-dihydroxy-5-substituted benzaldehyde 6.

Abstract: Provided is a method for preparing 2-hydroxy-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative represented by formula (I). The method comprises the following steps: (1) preparing 3-aryl-2-substituted toluene derivative 2 by using 3-iodo-2-substituted toluene derivative 1 and aryl boronic acid 5 or aryl boronate as starting materials; (2) preparing a benzyl halide derivative 3 by using 3-aryl-2-substituted toluene derivative 2 as starting materials; and (3) preparing 4-(2, 3-disubstituted benzyloxy)-2-hydroxy-5-substituted benzaldehyde derivative (I) by using benzyl halide derivative 3 and 2,4-dihydroxy-5-substituted benzaldehyde 6.

Abstract: The present invention discloses a nicotinyl alcohol ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to nicotinyl alcohol ether derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases.

Abstract: The present invention discloses a benzyl phenyl ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to benzyl phenyl ether derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases.

Abstract: The present invention discloses a phenylate derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to phenylate derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases.